The polygenic risk score appears to identify patients who may benefit most from LDL-lowering therapy, say researchers.
The polygenic risk score appears to identify patients who may benefit most from LDL-lowering therapy, say researchers.
一些您可能无法访问的结果已被隐去。
显示无法访问的结果